Literature DB >> 15655564

Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.

C Maddock, S Landau, K Barry, P Maulayah, M Hotopf, A J Cleare, S Norris, C M Pariante.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15655564     DOI： 10.1038/sj.mp.4001634

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  19 in total

Review 1.  The Immune System and the Role of Inflammation in Perinatal Depression.

Authors:  Philippe Leff-Gelman; Ismael Mancilla-Herrera; Mónica Flores-Ramos; Carlos Cruz-Fuentes; Juan Pablo Reyes-Grajeda; María Del Pilar García-Cuétara; Marielle Danitza Bugnot-Pérez; David Ellioth Pulido-Ascencio
Journal:  Neurosci Bull       Date:  2016-07-18       Impact factor: 5.203

2.  The emergence of obsessive compulsive and compulsive buying symptomatology after acute stress and short-term use of ribavirin: case reports.

Authors:  Görkem Karakaş Uğurlu; Mustafa Uğurlu; Ali Cayköylü
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

Review 3.  Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Authors:  J C Felger; F E Lotrich
Journal:  Neuroscience       Date:  2013-05-03       Impact factor: 3.590

4.  Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.

Authors:  Divya Mehta; Charles L Raison; Bobbi J Woolwine; Ebrahim Haroon; Elisabeth B Binder; Andrew H Miller; Jennifer C Felger
Journal:  Brain Behav Immun       Date:  2013-04-25       Impact factor: 7.217

5.  Depression and antiviral response to interferon-based therapy for hepatitis C virus infection.

Authors:  Jennifer M Loftis; Benjamin J Morasco; Peter Hauser
Journal:  Hepatology       Date:  2011-01-10       Impact factor: 17.425

6.  Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.

Authors:  Lucile Capuron; Giuseppe Pagnoni; Daniel F Drake; Bobbi J Woolwine; James R Spivey; Ronald J Crowe; John R Votaw; Mark M Goodman; Andrew H Miller
Journal:  Arch Gen Psychiatry       Date:  2012-10

7.  IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy.

Authors:  Francis E Lotrich; Jennifer M Loftis; Robert E Ferrell; Mordechai Rabinovitz; Peter Hauser
Journal:  J Interferon Cytokine Res       Date:  2010-12-06       Impact factor: 2.607

8.  Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.

Authors:  S J Bull; P Huezo-Diaz; E B Binder; J F Cubells; G Ranjith; C Maddock; C Miyazaki; N Alexander; M Hotopf; A J Cleare; S Norris; E Cassidy; K J Aitchison; A H Miller; C M Pariante
Journal:  Mol Psychiatry       Date:  2008-05-06       Impact factor: 15.992

Review 9.  Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics.

Authors:  Andrea H Marques; Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

10.  Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.

Authors:  C L Raison; A S Borisov; B J Woolwine; Breanne Massung; G Vogt; A H Miller
Journal:  Mol Psychiatry       Date:  2008-06-03       Impact factor: 15.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.